Veradigm Inc.

Veradigm Inc. is a healthcare technology company that provides clinical, financial, and analytical solutions to various stakeholders within the healthcare ecosystem. Headquartered in Chicago, Illinois, U.S., the company's mission is to improve healthcare outcomes through innovative technology solutions and to empower the healthcare community to advance patient care. It operates primarily through the Veradigm Network, which leverages platforms, data, expertise, connectivity, and scale to drive value.

Veradigm's key offerings include practice management and electronic health record (EHR) technology, patient engagement tools, care coordination solutions, and financial and analytics technology. The company provides a full spectrum of revenue cycle services, including coding, billing, collections, and claims management, and offers solutions like e-prescribing, gap closure alerts, and AI-powered patient scheduling. Its market segments encompass healthcare providers (physician practices, hospitals, and extended care organizations), life sciences organizations (such as pharmaceutical companies), and payers (health insurance companies).

Formerly known as Allscripts Healthcare Solutions, Inc., the company formally changed its name to Veradigm Inc. in January 2023. Veradigm was delisted from Nasdaq in February 2024 and now trades on the OTC Markets under the ticker MDRX, following non-compliance with listing rules related to financial reporting. The company is actively working to become current in its SEC filings and aims for relisting on Nasdaq by the end of 2026. Recent leadership changes include Tom Langan assuming the role of interim CEO in June 2024 and Christian Greyenbuhl being appointed CFO effective May 2026. Veradigm continues to focus on AI-enabled solutions, such as Veradigm Ambient Scribe, and initiatives for real-world evidence generation.